Fast Facts Latest News Upcoming Events     Rheoscience is a Danish biopharma- ceutical company focused on the discovery and development of novel pharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity.   Rheoscience has unparalleled experience in developing drugs for metabolic disorders and draws on this to advance its own pipeline of innovative compounds and to underpin its successful, profitable contract research business. 08 April 2008 Rheoscience A/S signes business agreement with Jap... Read More 13 February 2008 Rheoscience A/S announced that they have met the U... Read More 04 September 2007 Swami Subramaniam Appointed as Director, Business ... Read More 24 July 2008 CBI's 4th Annual Obesity Drug Development SummitTB... Read More 24 September 2008 SMi's Metabolic diseases conference Cepthorne Tara... Read More 03 October 2008 The Obesity Society Annual Scientific MeetingPhoen... Read More Contract Research       NOT YOUR TYPICAL CRO We deliver more than mere convenience. You get valuable insight. Expert sparring. Dedicated service – and a more effective race to market. Read more

RHEOSCIENCE A/S Glerupvej 2 DK-2610 Roedovre Denmark   Phone: +45 44501960 Fax: +45 44501962 Email: info@rheoscience.com   © Rheoscience       Legal notice